Evidence map›Paper›PMID 34145303›Full record

ArticleScientific reports2021

Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes.

Anna Esteve-Codina, Thomas P Hofer, Dorothe Burggraf, Marion S Heiss-Neumann, Wolfgang Gesierich, Anne Boland, Robert Olaso, Marie-Therese Bihoreau, Jean-Francois Deleuze, Winfried Moeller and 38 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Integrative multi-omics identifies CYP1B1 as a candidate molecular link between toxicant exposure and ferroptosis-related epithelial stress in COPD.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Mitochondria in health, disease, and aging.Physiological reviews · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 19 institutions in 8 countries.

Anna Esteve-CodinaCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Thomas P HoferEvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.
Dorothe BurggrafEvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.
Marion S Heiss-NeumannEvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.
Wolfgang GesierichEvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany.
Anne BolandCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.
Robert OlasoCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.
Marie-Therese BihoreauCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.
Jean-Francois DeleuzeCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France.
Winfried MoellerInstitute for Lung Biology and Disease, Helmholtz Zentrum Muenchen, Neuherberg-Munich, Germany.
Otmar SchmidInstitute for Lung Biology and Disease, Helmholtz Zentrum Muenchen, Neuherberg-Munich, Germany.
María Soler ArtigasCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Kathrin RennerInternal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Jens M HohlfeldFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Tobias WelteDepartment of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Thomas FuehnerDepartment of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Lukas JerrentrupMember of the German Center for Lung Research (DZL), Marburg, Germany.
Andreas Rembert KoczullaMember of the German Center for Lung Research (DZL), Marburg, Germany.
Timm GreulichMember of the German Center for Lung Research (DZL), Marburg, Germany.
Antje PrasseFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Joachim Müller-QuernheimDepartment of Pneumology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sumit GuptaInstitute for Lung Health, NIHR Leicester BRC, University of Leicester, Leicester, UK.
Christopher BrightlingInstitute for Lung Health, NIHR Leicester BRC, University of Leicester, Leicester, UK.
Deepak R SubramanianDepartment of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
David G ParrDepartment of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Umme KolsumMedicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.
Vandana GuptaMedicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.
Imre BartaDepartment of Pathophysiology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.
Balázs DömeDepartment of Tumorbiology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.
János StrauszDepartment of Pneumology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary.
Mariarita StendardoDepartment of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.
Marco PiattellaDepartment of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.
Piera BoschettoDepartment of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy.
Damian Korzybski2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Dorota Gorecka2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Adam Nowinski2nd Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Marc DabadCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Marcos Fernández-CallejoCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
David EndesfelderICT Department, Helmholtz Zentrum Muenchen, Munich, Germany.
Wolfgang Zu CastellDepartment Strategy & Digitalization, Helmholtz Zentrum Muenchen, Munich, Germany.
Pieter S HiemstraDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Per VengeDepartment of Medical Sciences, University of Uppsala, Uppsala, Sweden.
Elfriede NoessnerImmunoanalytics-Tissue Control of Immunocytes, Helmholtz Zentrum Muenchen, Munich, Germany.
Thasso GriebelCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Simon HeathCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Dave SinghMedicines Evaluation Unit, University of Manchester, University Hospital of South Manchester Foundations Trust, Manchester, UK.
Ivo GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Loems Ziegler-HeitbrockEvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany. Loems-EvA@gmx.de.
Asklepios Fachkliniken München-Gauting · DECentre for Genomic Regulation · ESGerman Center for Lung Research · DECEA Paris-Saclay · FRHelmholtz Zentrum München · DEOrszágos Korányi Tbc és Pulmonológiai Intézet · HUUniversity of Ferrara · ITMedicines Evaluation Unit · GBNIHR Leicester Biomedical Research Centre · GBUniversitat Pompeu Fabra · ESUniversity Hospitals Coventry and Warwickshire NHS Trust · GBFraunhofer Institute for Toxicology and Experimental Medicine · DELeiden University Medical Center · NLMedizinische Hochschule Hannover · DETechnical University of Munich · DEUniversity Hospital Regensburg · DEUniversity of Freiburg · DEUniversity of Manchester · GBUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a destructive inflammatory disease and the genes expressed within the lung are crucial to its pathophysiology. We have determined the RNAseq transcriptome of bronchial brush cells from 312 stringently defined ex-smoker patients. Compared to healthy controls there were for males 40 differentially expressed genes (DEGs) and 73 DEGs for females with only 26 genes shared. The gene ontology (GO) term "response to bacterium" was shared, with several different DEGs contributing in males and females. Strongly upregulated genes TCN1 and CYP1B1 were unique to males and females, respectively. For male emphysema (E)-dominant and airway disease (A)-dominant COPD (defined by computed tomography) the term "response to stress" was found for both sub-phenotypes, but this included distinct up-regulated genes for the E-sub-phenotype (neutrophil-related CSF3R, CXCL1, MNDA) and for the A-sub-phenotype (macrophage-related KLF4, F3, CD36). In E-dominant disease, a cluster of mitochondria-encoded (MT) genes forms a signature, able to identify patients with emphysema features in a confirmation cohort. The MT-CO2 gene is upregulated transcriptionally in bronchial epithelial cells with the copy number essentially unchanged. Both MT-CO2 and the neutrophil chemoattractant CXCL1 are induced by reactive oxygen in bronchial epithelial cells. Of the female DEGs unique for E- and A-dominant COPD, 88% were detected in females only. In E-dominant disease we found a pronounced expression of mast cell-associated DEGs TPSB2, TPSAB1 and CPA3. The differential genes discovered in this study point towards involvement of different types of leukocytes in the E- and A-dominant COPD sub-phenotypes in males and females.

Indexed as

Disease SusceptibilityGene ExpressionBiomarkersComputational BiologyFemaleGene Expression ProfilingHumansKruppel-Like Factor 4LeukocytesMaleMitochondriaPulmonary Disease, Chronic ObstructiveRespiratory MucosaSex FactorsTranscriptomeBiomarkersKLF4 protein, humanKruppel-Like Factor 4

Identifiers

PMID34145303
PMCPMC8213687
OpenAlexW3172960182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.